Scopolamine slows the orienting of attention in primates to cued visual targets

Psychopharmacology

Volumn 142, Issue 1, 1999, Pages 1-8

  Davidson, M C ^a   Cutrell, E B ^b   Marrocco, R T ^a  

^a UNIVERSITY OF OREGON   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Attention; Covert orienting; Monkey; Reaction time; Scopolamine; Working memory

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; ATTENTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MACACA; NONHUMAN; ORIENTING RESPONSE; PRIORITY JOURNAL; REACTION TIME; WORKING MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; MEMORY; MUSCARINIC ANTAGONISTS; REACTION TIME; SCOPOLAMINE; VISUAL FIELDS;

EID: 0032968453     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050855     Document Type: Article

References (31)

1. Anderson TJ, Jenkins IH, Brooks DJ, Hawken MB, Frackowiak RSJ, Kennard C (1994) Cortical control of saccades and fixation in man: a PET study. Brain 117:1073-1084
2. Bowman EM, Brown VJ, Kertzman C, Schwarz U, Robinson DL (1993) Covert orienting of attention in macaques. I. Effects of behavioral context. J Neurophysiol 70:431-443
3. Bushnell PJ, Chiba AA, Oshiro WM (1998) Effects of unilateral removal of basal forebrain cholinergic neurons on cued target detection in rats. Behav Brain Res 90:57-71
4. Callahan MJ, Kinsora JJ, Harbaugh RE, Reeder TM, Davis RE (1993) Continuous ICV infusion of scopolamine impairs sustained attention of rhesus monkeys. Neurobiol Aging 14:147-151
5. Duka T, Redemann B, Voet B (1995) Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing. Psychopharmacology 119:15-24
6. Duka T, Ott H, Rohloff A, Voet B (1996) The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills. Psychopharmacology 123:361-373
7. Gilman A, Goodman L, Rall T, Murad F (1985) The pharmacological basis of therapeutics. Macmillan, New York
8. Guide for the Care and Use of Laboratory Animals (1996) National Academy of Sciences, Washington, D.C.
9. Johnson MH (1994) Brain and cognitive development in infancy. Curr Opin Neurobiol 4:218-225
10. Jones D, Higgins G (1995) Effect of scopolamine on visual attention in rats. Psychopharmacology 120:142-149
11. Jones G, Sahakian B, Levy R, Warburton D, Gray J (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494
12. Judge S, Richmond B, Chu F (1980) Implantation of magnetic search coils for measurement of eye position: an improved method. Vision Res 20:535-538
13. Keppel G (1982) Design and analysis: a researcher's handbook. Prentice-Hall, Englewood Cliffs, N.J.
14. McGaughy J, Turchi J, Sarter M (1994) Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine. Psychopharmacology 115:213-220
15. Muir JL (1996) Attention and stimulus processing in the rat. Cogn Brain Res 3:215-225
16. Muir JL, Everitt BJ, Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14:2313-2326
17. Muller HJ, Rabbitt PM (1989) Reflexive and voluntary orienting of visual attention: time course of activation and resistance to interruption. J Exp Psychol [Hum Perform Percept] 15:315-330
18. Murphy F, Klein R (1998) The effects of nicotine on spatial and non-spatial expectancies in a covert orienting task. Neuropsychologia 36:1103-1114
19. Parasuraman R, Greenwood PM, Haxby JV, Grady CL (1992) Visuospatial attention in dementia of the Alzheimer type. Brain 115:711-733
20. Parrott A, Craig D (1992) Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasks. Neuropsychobiology 25:34-43
21. Posner MI (1980) Orienting of attention. Q J Exp Psychol 32:3-25
22. Posner MI, Cohen Y (1984) Components of attention. In: Bouma H, Bowhuis D (eds) Attention and performance X. Erlbaum, Hillsdale, N.J.
23. Posner MI, Petersen SE (1990) The attentional system of the human brain. Annu Rev Neurosci 13:25-42
24. Posner MI, Choate L, Rafal RD, Vaughan J (1985) Inhibition of return: neural mechanisms and function. Cognit Neuropsychol 2:211-228
25. Posner MI, Walker JA, Friedrich FA, Rafal RD (1987) How do the parietal lobes direct covert attention? Neuropsychologia 25:135-145
26. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attentionbut not learning and memory. J Neurosci 14:167-186
27. Warburton DM, Rusted R (1993) Cholinergic control of cognitive resources. Neuropsychobiol 28:43-46
28. Witte E (1994) Effects of catecholaminergic and cholinergic drugs on covert orienting of attention. Doctoral Dissertation, University of Oregon, Eugene, Ore., USA
29. Witte E, Marrocco R (1997) Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance. Psychopharmacology 134:324-334
30. Witte E, Villareal M, Marrocco R (1996) Visual orienting and alerting in rhesus monkeys: comparison with humans. Behav Brain Res 82:103-112
31. Witte E, Davidson M, Marrocco R (1997) Alteration of brain catecholaminc levels in rhesus monkeys affects the alerting component of covert orienting. Psychopharmacology 134:315-323